Regorafenib group:Regorafenib

A parallel, randomized, controlled phase III clinical trial comparing the efficacy and safety of regorafenib and furquintinib in the third line treatment of colorectal cancer

A prospective, randomized, positive drug parallel - controlled, open - label, multi - center phase II/III registrational clinical study of SH006 injection in combination therapy compared with regorafenib for the treatment of advanced hepatocellular carcinoma across the country.